Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 3,328.0 | 3,128.9 | 3,589.4 | 3,375.0 | 3,072.0 | 2,677.2 | 2,826.4 | 2,445.5 |
| Revenue growth | 6.4% | -12.8% | 6.4% | 9.9% | 14.7% | -5.3% | 15.6% | 2.1% |
| Cost of goods sold | 2,330.0 | 2,134.1 | 2,331.6 | 2,157.7 | 1,965.7 | 1,706.9 | 1,966.2 | 1,674.7 |
| Gross profit | 998.0 | 994.9 | 1,257.8 | 1,217.3 | 1,106.3 | 970.3 | 860.2 | 770.8 |
| Gross margin | 30.0% | 31.8% | 35.0% | 36.1% | 36.0% | 36.2% | 30.4% | 31.5% |
| Selling, general and administrative | 441.5 | 429.8 | 533.4 | 446.1 | 450.3 | 353.8 | 300.4 | 355.1 |
| Research and development | 54.0 | 59.2 | 58.3 | 70.1 | 84.3 | 80.5 | 89.2 | 88.3 |
| EBITA | 922.6 | 677.9 | 828.7 | 1,032.6 | 698.3 | 741.2 | 546.5 | 368.8 |
| EBITA margin | 27.7% | 21.7% | 23.1% | 30.6% | 22.7% | 27.7% | 19.3% | 15.1% |
| Amortization of intangibles | 25.3 | 24.9 | 27.1 | 28.0 | 25.1 | 19.0 | 16.9 | 5.7 |
| EBIT | 897.2 | 652.9 | 801.6 | 1,004.6 | 673.2 | 722.2 | 529.6 | 363.1 |
| EBIT margin | 27.0% | 20.9% | 22.3% | 29.8% | 21.9% | 27.0% | 18.7% | 14.8% |
| Pre-tax income | 133.6 | 373.5 | 563.0 | 794.7 | 446.8 | 515.3 | 310.7 | 213.2 |
| Income taxes | 29.4 | 54.4 | 88.2 | 144.8 | 431.8 | 96.3 | 11.1 | 18.5 |
| Tax rate | 22.0% | 14.6% | 15.7% | 18.2% | 96.6% | 18.7% | 3.6% | 8.7% |
| Earnings from continuing ops | 123.7 | 375.8 | 533.2 | 693.6 | 54.9 | 441.5 | 302.4 | 433.3 |
| Earnings from discontinued ops | | | | | | 202.1 | 32.5 | -69.5 |
| Net income | 123.7 | 375.8 | 533.2 | 693.6 | 54.9 | 643.7 | 334.9 | 363.8 |
| Net margin | 3.7% | 12.0% | 14.9% | 20.6% | 1.8% | 24.0% | 11.8% | 14.9% |
| |
| Diluted EPS | $1.06 | $3.52 | $5.02 | $6.34 | $0.49 | $3.90 | $2.71 | $5.48 |
| Shares outstanding (diluted) | 116.5 | 106.8 | 106.3 | 109.5 | 112.4 | 113.2 | 111.6 | 79.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|